March 2025 Project Updates Closing the Cancer Screening Gap: Europe's Collaborative Solutions WP1 Disparities in access, quality, and implementation of screening programmes exist across different European countries. Where you live and your socioeconomic status can heavily influence your chances of getting screened for cancer. These disparities translate into real health consequences. Lower screening
Read More
March 2025 Project Updates Driving Progress in Cancer Screening: EUCanScreen's Deliverables WP1 The EUCanScreen project is progressing steadily, marking significant achievements in its mission to enhance cancer screening across Europe. To date, we have successfully reached eight milestones and submitted five key deliverables, reinforcing our commitment to high-quality and sustainable screening programmes. One of
Read More
March 2025 Project Updates Welcome Message Dear Readers, As the project scientific lead I’m delighted to welcome you to the first edition of the EUCanScreen Newsletter! EUCanScreen unites prominent experts, researchers, and policymakers from all over Europe to encourage worldwide cooperation in cancer screening. This ambitious initiative aims to build a strong and long-lasting European
Read More
ΣΥΛΛΟΓΟΣ ΕΘΕΛΟΝΤΩΝ ΑΙΜΟΔΟΤΩΝ ΚΕΝΤΡΟΥ ΥΓΕΙΑΣ ΧΑΛΑΝΔΡΙΤΣΑΣ «Ο ΑΓΙΟΣ ΧΑΡΑΛΑΜΠΟΣ» ΜΕΛΟΣ ΠΑΝΕΛΛΗΝΙΑΣ ΟΜΟΣΠΟΝΔΙΑΣ ΣΥΛΛΟΓΩΝ ΕΘΕΛΟΝΤΩΝ ΑΙΜΟΔΟΤΩΝ (Π.Ο.Σ.Ε.Α.) ΤΗΛ: 2694022869, 6974749437 FAX: 26940 2286 / 2610 322502 e-mail ΔΕΛΤΙΟ ΤΥΠΟΥ Xαλανδρίτσα 21/3/2025 Ο Σύλλογος Εθελοντών Αιμοδοτών Κέντρου Υγείας Χαλανδρίτσας σε συνεργασία με το τμήμα Αιμοδοσίας του Γ.Ν.Π «Ο Άγιος Ανδρέας» και την
Read More
Yaremche, Ukraine, March 2025 EUCanScreen Project Participants Held the "Minimally Invasive Technologies in Urology" Conference, Presenting the Project and Discussing the Importance of Improving Cancer Screening Programs The scientific and practical conference "Minimally Invasive Technologies in Urology" took place in Yaremche, Ivano-Frankivsk region. The event was organized by the Association of Urologists
Read More
